SAN FRANCISCO (CBS.MW) -- Elan surged 34 percent in U.S. trading Wednesday on hopes that a multiple sclerosis therapy could soon win U.S. approval. However, declines from Vodafone and Reuters helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback